Value, Evidence & Outcomes (VEO) Senior Scientist, Open to flexible working

Brentford (City/Town), London (Greater)
06 Sep 2020
18 Sep 2020
Contract Type

The Value Evidence & Outcomes (VEO) senior scientist is part of the regional VEO team in Europe, and the wider Global VEO group. The Regional Team is essential in successful reimbursement and optimal launch update for GSK assets via identification and generation of the right value evidence package. The team supports assets in in respiratory, speciality and, importantly, in oncology. It is led by the regional VEO Scientific Lead to whom 2 regional scientists report.

The role of the VEO Regional Scientist is essential to development and execution of Real World Evidence (RWE) research projects to support the right value evidence package. In collaboration with the VEO regional lead and alignment with regional Medical and Market Access teams and LOCs, the VEO regional scientist is required to:

  • Plan health outcomes projects (economic evaluations and Real World Research) aligned to the global and regional Integrated Evidence Plan (IEP), and ensure oversight or delivery of high quality scientifically robust value evidence supporting reimbursement, HTA assessments, product differentiation, and other customers' needs.
  • Work in partnership with regional and local Market Access, Medical, Commercial functions, aligned with the regional VEO lead and supporting interactions with global teams.
  • Manage multiple projects, timelines, deliverables, and budget in alignment with corporate governance and policy.
  • Identify resources, references and analyses to inform projects about scientific design to inform internal stakeholders and external experts as needed.



  • Contribute to the development of the regional integrated evidence plan (IEP) based on local needs identified. To help identify global and regional synergies when developing the strategy for evidence generation activities
  • Participate in discussions to guide LOC in defining evidence gaps and local evidence generation strategies consistent with the global and regional IEPs and local needs.
  • Review and support local submissions for reimbursement or HTA considering global Value Evidence Dossier and local evidence.


  • Provide expertise in translating identified needs for evidence into study concepts and study protocols (prospective or retrospective observational research/RWE, economic models, burden of disease) in alignment with strategic objectives of IEP and vision established by the region. Propose innovative and cost-effective ways of developing studies.
  • Plan, conduct and deliver selected health outcome projects and activities (RWE, adaptation of economic models, literature searches etc. including publications of results in collaboration with internal teams and external experts. Collaborate with regional team, LOC and external experts on project development. Train LOCs to communicate the project to external experts, including negotiation with payers.
  • Organise evidence into robust argumentation for use by LOC in their local evidence dossier and in discussions with reimbursement organisations.
  • Map existing real-world data sources in the region and become the point of contact to advice on their suitability to address given research questions. Have a good knowledge of the existing partnership or public initiatives around evidence generation in the region
  • Develop a deep understanding of customers' needs in the region, including HTA requirements, as well as the of acceptance of RWE or economic evidence and impact to the decision making of different customers (reimbursement, medical societies, physicians)


  • Guide LOCs on successful conduct of local health outcomes activities in collaboration with vendors and local external experts. Support LOCs to ensure delivery of projects of scientific quality in compliance with internal and external governance and policy, and optimal integration of projects outcomes into local communication strategies or submission dossiers;
  • Collaborate with internal teams to share global VEO deliverables (global Value Evidence Dossier, RWE studies), and to organise best practice sharing sessions across the region
  • Partner with internal teams to deliver subject related trainings (economic model adaptations, HTA environment, RWE/Epidemiology methodology)


CLOSING DATE for applications: 18th September 2020

Please take a copy of the Job Description, as this will not be available post closure of the advert.

When applying for this role, please use the 'cover letter' of the online application or your CV to describe how you meet the competencies for this role, as outlined in the job requirements above. The information that you have provided in your cover letter and CV will be used to assess your application.

Why you?

Basic Qualifications:

We are looking for professionals with these required skills to achieve our goals:

  • Master's degree in health economics, epidemiology, public health, evidence-based medicine or similar.
  • 3-5 years of experience in health outcomes, epidemiology or similar function within the pharmaceutical industry, consultancy or academia
  • Educational background with technical expertise consistent with scientific project planning, implementation, and delivery of evidence.
  • Familiarity with Health Technology Assessment bodies (HTAs) in multiple markets in Europe or experience in providing health outcomes support for a local operating company (LOC)
  • Knowledge in design of Real World Evidence (RWE) studies, development of study protocols, implementation of studies and experience in local dossier and economic model development
  • Ability to function and to collaborate effectively in a multi-disciplinary team and multi-cultural setting. Agility in addressing multiple requests and team-oriented mindset.
  • Good communication skills in both written and verbal English. Additional languages relevant to region preferred.
  • Ability to travel up to 15-25% of the time in the region

Preferred Qualifications:

If you have the following characteristics, it would be a plus:

  • PhD in relevant discipline
  • 5+ years of experience in health outcomes or similar function within the pharmaceutical industry, consultancy or academia
  • Previous cross-portfolio and above country experience

Why GSK?

At GSK, we're a company with a special purpose, to help people do more feel better and live longer. Realising our purpose starts with us. When we feel at our best, we perform at our best.

When you set out on your adventure at GSK, we make a deal. You commit to living GSK's values and expectations and performing against our Innovation, Performance and Trust priorities. And in return, GSK commits to providing the right environment for you to thrive. Put simply, it's about you being motivated to do your best work, in a place where you can be you, feel good and keep growing.

Together we build an environment where we can all thrive and focus on what matters most to each of us. It is only through the energy, dedication, drive and passion of all of us that we can be the very best for GSK, and importantly, for our patients and consumers.

As a company driven by our values of Patient focus, Transparency, Respect and Integrity, we know inclusion and diversity are essential for us to be able to succeed. We want all our colleagues to thrive at GSK bringing their unique experiences, ensuring they feel good and to keep growing their careers. As a candidate for a role, we want you to feel the same way.

As an Equal Opportunity Employer, we are open to all talent. In the US, we also adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to race/ethnicity, colour, national origin, religion, gender, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class*(*US only).

We believe in an agile working culture for all our roles. If flexibility is important to you, we encourage you to explore with our hiring team what the opportunities are.

Please don't hesitate to contact us if you'd like to discuss any adjustments to our process which might help you demonstrate your strengths and capabilities. 

As you apply, we will ask you to share some personal information which is entirely voluntary. We want to have an opportunity to consider a diverse pool of qualified candidates and this information will assist us in meeting that objective and in understanding how well we are doing against our inclusion and diversity ambitions. We would really appreciate it if you could take a few moments to complete it. Rest assured, Hiring Managers do not have access to this information and we will treat your information confidentially.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorisation before referring any candidates to GSK. The obtaining of prior written authorisation is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorisation being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK's compliance to all federal and state US Transparency requirements.